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Clinics and pathology 
Epidemiology 
Occurs in the elderly (med 70 years); sex ratio 
2M/1F. 
Clinics 
Splenomegaly without hepatomegaly nor enlarged 
lymph nodes; peripheral blood lymphocytes with 
villous projections; monoclonal Ig in half cases. 
Cytology 
B-cells expressing CD19+, CD20+, CD22+, 




5-year survival: 80%; adverse prognostic factors: 
WBC above 30 x 109/l, low lymphocyte count; 




The karyotype is often abnormal: 
- del(7q) and translocations involving 7q (20% of 
cases), 
- t(11;14)(q13;q32) (15%), 





Genes involved and 
proteins 
Note 
BCL1 in 11q13 and IgH in 14q32 are involved in 
20% of cases, with or without a visible t(11;14); 
BCL1 encodes the cyclin D1; role in the cell cycle 
control (G1 progression and G1/S transition); 5' 
BCL1 translocated on chromosome 14 near JH, 
resulting in promoter exchange; the 
immunoglobulin gene enhancer stimulates the 
expression of BCL1, and overexpression of BCL1 
which accelerates passage through the G1 phase; 
microdeletion in the RB1 region in half cases. 
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